GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabotech Ltd (XTAE:CNTC) » Definitions » Additional Paid-In Capital

Cannabotech (XTAE:CNTC) Additional Paid-In Capital : ₪0.00 Mil(As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is Cannabotech Additional Paid-In Capital?



Cannabotech Additional Paid-In Capital Historical Data

The historical data trend for Cannabotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabotech Additional Paid-In Capital Chart

Cannabotech Annual Data
Trend
Additional Paid-In Capital

Cannabotech Semi-Annual Data
Additional Paid-In Capital

Cannabotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Cannabotech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Cannabotech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabotech (XTAE:CNTC) Business Description

Traded in Other Exchanges
N/A
Address
Arik Einstein 3, Herzliya, ISR, 4610301
Cannabotech Ltd is engaged in the research and development of cannabis-based drugs. It is a biomedical company focused on the benefits of cannabinoids and medicinal mushrooms, applying the pure power of nature and science to health issues.

Cannabotech (XTAE:CNTC) Headlines

No Headlines